Mark Massaro
Stock Analyst at BTIG
(4.64)
# 184
Out of 5,090 analysts
170
Total ratings
57.62%
Success rate
23.08%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Reiterates: Buy | $160 | $118.65 | +34.85% | 4 | Dec 3, 2025 | |
| BLLN BillionToOne | Initiates: Buy | $160 | $111.64 | +43.32% | 1 | Dec 1, 2025 | |
| TEM Tempus AI | Maintains: Buy | $96 → $105 | $76.66 | +36.97% | 6 | Nov 25, 2025 | |
| EXAS Exact Sciences | Downgrades: Neutral | n/a | $101.06 | - | 20 | Nov 20, 2025 | |
| MDXH MDxHealth | Maintains: Buy | $6 → $7 | $3.60 | +94.44% | 9 | Nov 13, 2025 | |
| PSNL Personalis | Maintains: Buy | $11 → $12 | $9.56 | +25.52% | 3 | Nov 11, 2025 | |
| XGN Exagen | Maintains: Buy | $13 → $15 | $7.20 | +108.33% | 5 | Nov 10, 2025 | |
| SOPH SOPHiA GENETICS | Maintains: Buy | $6 → $7 | $4.85 | +44.33% | 3 | Nov 10, 2025 | |
| NTRA Natera | Maintains: Buy | $210 → $230 | $244.55 | -5.95% | 15 | Nov 7, 2025 | |
| CDNA CareDx | Maintains: Buy | $22 → $25 | $18.53 | +34.92% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $21 | $14.75 | +42.37% | 7 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $38 | $38.65 | -1.68% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $785 → $830 | $714.10 | +16.23% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $100 | $102.02 | -1.98% | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $165 | $158.96 | +3.80% | 6 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.03 | +142.72% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $6 → $9 | $9.25 | -2.70% | 7 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.47 | - | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.68 | - | 8 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $11.90 | +76.47% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.80 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.06 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $128.96 | +132.63% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $74.97 | -33.31% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $182.51 | -38.63% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $258.39 | -36.14% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $27.76 | +188.18% | 9 | Sep 10, 2018 |
Zoetis
Dec 3, 2025
Reiterates: Buy
Price Target: $160
Current: $118.65
Upside: +34.85%
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $160
Current: $111.64
Upside: +43.32%
Tempus AI
Nov 25, 2025
Maintains: Buy
Price Target: $96 → $105
Current: $76.66
Upside: +36.97%
Exact Sciences
Nov 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $101.06
Upside: -
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $3.60
Upside: +94.44%
Personalis
Nov 11, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $9.56
Upside: +25.52%
Exagen
Nov 10, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $7.20
Upside: +108.33%
SOPHiA GENETICS
Nov 10, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $4.85
Upside: +44.33%
Natera
Nov 7, 2025
Maintains: Buy
Price Target: $210 → $230
Current: $244.55
Upside: -5.95%
CareDx
Nov 6, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $18.53
Upside: +34.92%
Nov 6, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $14.75
Upside: +42.37%
Nov 5, 2025
Maintains: Buy
Price Target: $32 → $38
Current: $38.65
Upside: -1.68%
Nov 4, 2025
Maintains: Buy
Price Target: $785 → $830
Current: $714.10
Upside: +16.23%
Oct 30, 2025
Maintains: Buy
Price Target: $80 → $100
Current: $102.02
Upside: -1.98%
Oct 29, 2025
Maintains: Buy
Price Target: $140 → $165
Current: $158.96
Upside: +3.80%
Sep 10, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.03
Upside: +142.72%
Aug 25, 2025
Maintains: Sell
Price Target: $6 → $9
Current: $9.25
Upside: -2.70%
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.47
Upside: -
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.68
Upside: -
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $11.90
Upside: +76.47%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.80
Upside: -
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.06
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $128.96
Upside: +132.63%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $74.97
Upside: -33.31%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $182.51
Upside: -38.63%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $258.39
Upside: -36.14%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $27.76
Upside: +188.18%